Savvy Trades and Investments

[value1008]

HLTH - as some of you noted back in Dec. analyst Charles Haff from Craig Hallum severely downgraded his price target on HLTH from $6 to $2, and from Buy to Hold. That surely has had a chilling effect on this stock. The Canaccord analyst hasn't updated anything since last Sept.'s "Buy" and $4.80 target. One would think he/she would have stepped up and reiterated something since the C.Hallum analyst stated his piece.
(See https://www.marketbeat.com/stocks/NYSE/HLTH/ for latest analyst ratings)

From the Q&A on last conf call, it was made clear that the increased G&A was "pulled forward" from Q4 to Q3, and mgmt promised lower G&A for Q4 and better profitability.

Here is the most recent profile of institutional ownership of HLTH— https://fintel.io/so/us/hlth
...it's very uneven, with Hillsdale being the biggest buyer by far in Q3 but then it dumped all 1.3 million shares in Q4 or perhaps the present Q1, according to a filing on 2/16/17 (that may have been a late filing for Q4). Vanguard dumped 90% of its 1.1 million shares. McKinley Capital dumped all 588k of its shares. Seems lots of 'tutes sold this one heavily after last earnings report(s). Yet some 'tutes have upped their holdings significantly, such as Deutsch Bank increasing from 13k shares to 507k shares.


Also, there was an 8-k filed today at 5 pm -- http://seekingalpha.com/filing/3452287
Can anyone figure out the financial legalese on this one? Is it "good or bad news"?

I would remind people that the only fairly recent S.Alpha article on HLTH dates from last August and was rather cautious on buying the stock.

Nevertheless, if HLTH can post EPS of 0.30 for 2016 (as SSK has prognosticated), and do the same or better for 2017, then this one is surely undervalued below $2 or in low $2s.